CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP) (Institutional affiliation for the last research proposal) Birthplace: Brazil
Farmacêutico Generalista pela Universidade Estadual do Oeste do Paraná (UNIOESTE, 2010), Mestre (2015) e Doutor (2019) em Ciências pela FCFRP-USP (Faculdade de Ciências Farmacêuticas de Ribeirão Preto-Universidade de São Paulo), pelo Programa de Pós-Graduação em Ciências Farmacêuticas na linha de pesquisa: Produtos Naturais e Sintéticos. Atualmente é professor Adjunto A da Universidade Federal de Santa Maria (UFSM) nas disciplinas de Química Farmacêutica e Síntese e Elucidação Estrutural de Fármacos. Atua principalmente em estudos de síntese e exploração da reatividade química de compostos heterocíclicos visando a obtenção de compostos biologicamente ativos. E-mail contato: fernando.fumagalli@ufsm.br (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
It is clear the need for development of new drugs. Although, the increasing knowledge of the macromolecular mechanisms of several diseases allowed the identification of therapeutic targets, the development of drugs for these targets did not follow the same rate. Nowadays, the fast and efficient development of new drugs have been reached by used of Fragment-Based Drug Discovery (FBDD) stra…
The leishmaniasis is a neglected disease that affects millions of people worldwide, mainly in tropical countries. This disease is caused by Leishmania spp., and has two clinical form: cutaneous and visceral. Currently there are few therapeutic options for this disease, and the search for new drugs has been the subject of research. In this scenario recent studies showed carbazoles alkaloid…
The fast and efficient development of new drugs have been reached by using modern strategies as the Fragment-Based Drug Discovery (FBDD), which from a screened fragment with low potency, a lead compound is obtained by optimization process. For this, the heteroaromatics compounds highlight as good fragments because of their physicochemical and electronic proprieties. So far, our group has …
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |